Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 2.760
-0.020 (-0.72%)
May 28, 2026, 4:19 PM CET
Arterra Bioscience Market Cap
Arterra Bioscience has a market cap or net worth of €18.51 million as of May 28, 2026. Its market cap has increased by 23.01% in one year.
Market Cap
18.51M
Enterprise Value
17.43M
Revenue
4.70M
Ranking
n/a
PE Ratio
9.23
Stock Price
€2.76
Market Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has decreased from 22.33M to 18.51M, a decrease of -17.09%. That is a compound annual growth rate of -2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 18.51M | -7.95% |
| Dec 30, 2025 | 20.11M | 54.08% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.44B |
| DiaSorin | 3.48B |
| Amplifon | 2.34B |
| EL.En. | 1.19B |
| GPI S.p.A. | 426.97M |
| Svas Biosana | 47.42M |
| Talea Group | 40.74M |
| Otofarma S.P.A. | 20.26M |